HC Wainwright began coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research note released on Thursday, MarketBeat reports. The brokerage issued a buy rating and a $55.00 price objective on the biopharmaceutical company’s stock. Several other research analysts have also recently weighed in on AGIO. Bank of America boosted their price […]

Analysts at Needham & Company LLC began coverage on shares of Diodes (NASDAQ:DIOD – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. The firm set a “buy” rating and a $110.00 price target on the semiconductor company’s stock. Needham & Company LLC‘s target price suggests a potential upside of […]